Regeneron - Invidious

Regeneron

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.

View channel on YouTube

Switch Invidious Instance

Shorts

newest

oldest

popular

1:00

Connor Hill, Top Winner of the 2026 Regeneron Science Talent Search

Regeneron

Shared 56 years ago

10K views

1:00

Who is qualified to participate in a clinical trial?

Regeneron

Shared 56 years ago

164 views

1:00

Let’s Get Real About Skin Cancer: Sun Protection is a Team Effort [60s Short]

Regeneron

Shared 56 years ago

560 views

1:00

Did you answer correctly?

Regeneron

Shared 56 years ago

196 views

1:00

Investing in People: Regeneron’s Workforce and Community Goals

Regeneron

Shared 56 years ago

100 views

1:00

Evolving Bispecific Antibody Technology | Tech Trailblazers, Ep. 4

Regeneron

Shared 56 years ago

215 views

1:00

Environmental Sustainability in Regeneron’s 2030 Goals

Regeneron

Shared 56 years ago

95 views

1:00

Forget TikTok. Most people hear about trials here.

Regeneron

Shared 56 years ago

135 views

1:00

Can you guess what this is?

Regeneron

Shared 56 years ago

121 views

1:00

Regeneron ISEF 2026: A Global Experience

Regeneron

Shared 56 years ago

201K views

1:00

Supporting Access to Medicines: Regeneron’s 2030 Goals

Regeneron

Shared 56 years ago

208 views

1:00

Science is at the Core of Regeneron’s Responsibility Strategy

Regeneron

Shared 56 years ago

98 views

1:00

Radical Innovation: Break the Genetic Bottleneck with VelociGene®

Regeneron

Shared 56 years ago

180 views

1:00

Regeneron International Science and Engineering Fair 2026: More Than a Science Fair

Regeneron

Shared 56 years ago

161K views

1:00

Finding Data Worth Trusting with Christina Beechert | Tech Trailblazers, Ep. 3

Regeneron

Shared 56 years ago

419 views

1:00

3 facts you should know about clinical trials

Regeneron

Shared 56 years ago

131 views

1:00

What do you see?

Regeneron

Shared 56 years ago

73 views

1:00

10 Years of Regeneron STS Impact

Regeneron

Shared 56 years ago

231 views

1:00

Why do people join clinical trials? Here’s the top reason

Regeneron

Shared 56 years ago

128 views

1:00

What do you think this is?

Regeneron

Shared 56 years ago

145 views

1:00

Radical Innovation: Breaking the genetic engineering bottleneck

Regeneron

Shared 56 years ago

143 views

1:00

Regeneron STS 2026 Recap

Regeneron

Shared 56 years ago

356 views

1:00

Be Extraordinary: Meet Matteo Paz | 2025 STS Winner

Regeneron

Shared 56 years ago

389 views

1:00

Regeneron Science Talent Search: $150M Investment in Future Scientific Leaders

Regeneron

Shared 56 years ago

426K views

1:00

Be Extraordinary: Fueled by Legends | The Regeneron Science Talent Search's Impact

Regeneron

Shared 56 years ago

46K views

1:00

Patients trust this source the most. It’s not social media.

Regeneron

Shared 56 years ago

157 views

1:00

Be Extraordinary: Fueled by Legends | How Regeneron Science Talent Search Shapes Scientific Impact

Regeneron

Shared 56 years ago

130K views

1:00

Radical Innovation: Creating Simple Solutions for Patients

Regeneron

Shared 56 years ago

109 views

1:00

Be Extraordinary: Fueled by Legends | How the Regeneron Science Talent Search Fuels Confidence

Regeneron

Shared 56 years ago

213K views

1:00

Be Extraordinary: Fueled by Legends I The Regeneron Science Talent Search Experience

Regeneron

Shared 56 years ago

270K views

1:00

Radical Innovation: How Veloci-Bi® Powers Scientific Breakthroughs

Regeneron

Shared 56 years ago

114K views

1:00

Clinical Trials Day 2025: Powered By Purpose

Regeneron

Shared 56 years ago

100 views

1:00

Clinical Trials Day 2025: You Make It Possible

Regeneron

Shared 56 years ago

179 views

1:00

Clinical Trials Day 2025: Thank You

Regeneron

Shared 56 years ago

53 views

1:00

Do you think you know who qualifies for a trial? Think again.

Regeneron

Shared 56 years ago

62 views

1:00

What do you think you’re looking at?

Regeneron

Shared 56 years ago

292 views

1:00

Introducing STEM-Fueled

Regeneron

Shared 56 years ago

458 views

1:00

Celebrating Regeneron Day for Doing Good 2025

Regeneron

Shared 56 years ago

370 views

1:00

Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou

Regeneron

Shared 56 years ago

206 views

1:00

Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou

Regeneron

Shared 56 years ago

109 views

1:00

Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou

Regeneron

Shared 56 years ago

132 views

1:00

How Regeneron Scientists Study Disease Up Close

Regeneron

Shared 56 years ago

91 views

1:00

Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik

Regeneron

Shared 56 years ago

333 views

1:00

Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik

Regeneron

Shared 56 years ago

242 views

1:00

Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik

Regeneron

Shared 56 years ago

299 views

1:00

Can you guess what this is?

Regeneron

Shared 56 years ago

166 views

1:00

Can you tell what you're looking at? 👀

Regeneron

Shared 56 years ago

160 views

1:00

Can you tell what you're looking at? 👀 — Part 2

Regeneron

Shared 56 years ago

159 views